老虎证券

Bio-Rad Labs misses Q3 estimates for profit, revenue

seekingalpha
2024-11-01
  • Bio-Rad Labs press release (NYSE:BIO): Q3 Non-GAAP EPS of $2.01 misses by $0.87.
  • Revenue of $649.7M (+2.8% Y/Y) misses by $32.45M.
  • Bio-Rad continues to expect its non-GAAP revenue to decline by approximately 2.5% to 4% on a currency-neutral basis.
  • The company estimates a non-GAAP operating margin of between 12.75% to 13.25%, which now also includes the impact of a one-time acquired in-process research and development expense related to an acquisition completed during the third quarter.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10